Catalio Capital Management

Catalio Capital Management is a life sciences investment firm that focuses on breakthrough biomedical technology companies.

gold gold bracelet

Biotech

Third Rock, Novo Holdings-backed Clasp hooks $150M series A

A new immuno-oncology biotech has emerged, clasping $150 million that will go toward developing next-gen T cell engagers.

Gabrielle Masson Mar 20, 2024 7:00am

maps navigate compass

Cartography gets on the map with $57M for immunotherapies

Jul 19, 2022 10:00am

Parachute

Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders

May 27, 2022 9:30am

Role of hundred dollar bills on other bills

Catalio reloads with $381M after financing Octant, Pheast

May 4, 2022 9:21am